1. Home
  2. AZZ vs BLLN Comparison

AZZ vs BLLN Comparison

Compare AZZ & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AZZ Inc.

AZZ

AZZ Inc.

HOLD

Current Price

$153.24

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

HOLD

Current Price

$93.91

Market Cap

4.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZZ
BLLN
Founded
1956
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.6B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
AZZ
BLLN
Price
$153.24
$93.91
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
$141.80
$126.71
AVG Volume (30 Days)
216.2K
795.0K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
0.58%
N/A
EPS Growth
486.59
103.40
EPS
1.72
0.48
Revenue
$1,061,817,000.00
$305,112,000.00
Revenue This Year
$7.03
$46.29
Revenue Next Year
$4.25
$30.14
P/E Ratio
$87.99
$194.44
Revenue Growth
14.53
99.97
52 Week Low
$92.98
$61.96
52 Week High
$162.20
$150.44

Technical Indicators

Market Signals
Indicator
AZZ
BLLN
Relative Strength Index (RSI) 53.68 37.20
Support Level $132.06 $73.46
Resistance Level $152.83 $99.29
Average True Range (ATR) 3.87 6.90
MACD 0.19 -4.42
Stochastic Oscillator 67.64 11.29

Price Performance

Historical Comparison
AZZ
BLLN

About AZZ AZZ Inc.

AZZ Inc is a provider of galvanizing and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of AZZ Metal Coatings, AZZ Precoat Metals, and AZZ Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company operates in the United States and Canada.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: